首页|血清YKL-40、PON-1与高血压脑出血患者血肿清除术后发生迟发性脑水肿的关系

血清YKL-40、PON-1与高血压脑出血患者血肿清除术后发生迟发性脑水肿的关系

扫码查看
目的 探讨人软骨糖蛋白-39(YKL-40)、对氧磷酶-1(PON-1)与高血压脑出血患者血肿清除术后发生迟发性脑水肿的关系,以期为临床治疗提供参考.方法 选取2021年1月—2024年1月在合肥市第八人民医院接受血肿清除术治疗的122例高血压脑出血患者作为研究组,根据术后14 d是否发生迟发性脑水肿分为发生组(n=42)、未发生组(n=80).另将同期在合肥市第八人民医院体检的138例健康人作为对照组.所有研究对象均检测血清YKL-40、PON-1水平;收集研究组患者一般资料;采用受试者工作特性曲线(ROC)评估血清YKL-40、PON-1对迟发性脑水肿的预估价值;采用多因素回归分析探讨高血压脑出血患者术后发生迟发性脑水肿的危险因素.结果 研究组患者YKL-40水平高于对照组,PON-1水平低于对照组,差异均有统计学意义(P<0.05).发生组患者YKL-40水平高于未发生组,PON-1水平低于未发生组,差异均有统计学意义(P<0.05).ROC曲线结果显示:YKL-40、PON-1预估高血压脑出血患者血肿清除术后发生迟发性脑水肿的AUC分别为0.801(95%CI:0.751~0.851)、0.846(95%CI:0.796~0.896),血清YKL-40联合PON-1预估的AUC为0.910(95%CI:0.860~0.960).多因素逐步回归分析结果显示,高血压病程>5.2年[OR(95%CI)=2.149(1.617~2.855)]、美国国立卫生研究院卒中量表(NIHSS)评分>7分[OR(95%CI)=1.900(1.464~2.466)]、血肿体积>45.0 m L[OR(95%CI)=3.360(1.952~5.783)]及血清YKL-40>43.52 μg/L[OR(95%CI)=2.664(1.759~4.037)]、PON-1≤88.94 μg/m L[OR(95%CI)=3.916(2.079~7.375)]均为影响高血压脑出血患者血肿清除术后发生迟发性脑水肿的危险因素(P<0.05).结论 高血压脑出血患者血清YKL-40水平异常升高,PON-1水平异常降低,且二者水平变化与患者血肿清除术后迟发性脑水肿发生密切相关,有望作为术后迟发性脑水肿发生的辅助预估生物标志物,且二者联合对术后迟发性脑水肿发生的预估具有更高的临床价值.
Relationship between YKL-40,PON-1,and delayed cerebral edema after hematoma evacuation in hypertensive intracerebral hemorrhage patients
Objective To investigate the relationship between serum human cartilage glycoprotein-39(YKL-40),paraoxo-nase-1(PON-1),and the occurrence of delayed cerebral edema(DCE)after hematoma evacuation in patients with hyperten-sive intracerebral hemorrhage,aiming to provide a reference for clinical treatment.Methods A total of 122 patients with hypertensive intracerebral hemorrhage who underwent hematoma evacuation at the Eighth People's Hospital of Hefei from January 2021 to January 2024 were selected as the study group.According to the occurrence of DCE within 14 days post-sur-gery,the patients were assigned to the DCE group(n=42)and the non-DCE group(n=80).Additionally,138 healthy in-dividuals who underwent physical examinations at the same hospital during the same period were included as the control group.All study participants had their serum YKL-40 and PON-1 levels measured.General information for the patients in the study group was also collected.The receiver operating characteristic(ROC)curve was used to evaluate the value of ser-um YKL-40 and PON-1 in predicting DCE after hematoma evacuation.Multivariate regression was used to analyze the risk factors for DCE after surgery in patients with hypertensive intracerebral hemorrhage.Results The YKL-40 levels in the study group were significantly higher than those in the control group,while the PON-1 levels were significantly lower(P<0.05).In the DCE group,YKL-40 levels were significantly higher and PON-1 levels were significantly lower than those in the non-DCE group(P<0.05).The ROC curve results showed that the areas under the curve(AUC)for YKL-40 and PON-1 in assessing the occurrence of DCE in hypertensive intracerebral hemorrhage patients after hematoma evacuation were 0.801(95%CI:0.751-0.851)and 0.846(95%CI:0.796-0.896),respectively.The combined AUC for serum YKL-40 and PON-1 was 0.910(95%CI:0.860-0.960).Multivariate stepwise regression analysis revealed that the following factors were risk factors for DCE after hematoma evacuation in patients with hypertensive intracerebral hemorrhage:hyper-tension duration>5.2 years[OR(95%CI)=2.149(1.617-2.855)],National Institutes of Health Stroke Scale(NIH-SS)score>7[OR(95%CI)=1.900(1.464-2.466)],hematoma volume>45.0 m L[OR(95%CI)=3.360(1.952-5.783)],serum YKL-40>43.52 μg/L[OR(95%CI)=2.664(1.759-4.037)],and PON-1≤88.94 μg/m L[OR(95%CI)=3.916(2.079-7.375)](P<0.05).Conclusion In hypertensive intracerebral hemorrhage patients,serum YKL-40 levels are significantly elevated and PON-1 levels are significantly reduced.These changes are closely associated with the occurrence of DCE after hematoma evacuation.Serum YKL-40 and PON-1 may serve as potential biomarkers for the auxiliary assessment of DCE post-surgery.The combination of both biomarkers provides higher clinical value for evalua-ting the risk of DCE.

Hypertensive intracerebral hemorrhageHematoma evacuationYKL-40Paraoxonase-1Delayed cerebral edema

赵富刚、管鹏、田觅、夏旭东、方毅琳、牛森、陈炜钰

展开 >

安徽省合肥市第八人民医院神经外科,合肥 238000

复旦大学附属华山医院神经外科,上海 200030

安徽省合肥市第八人民医院神经内科,合肥 238000

高血压脑出血 血肿清除术 人软骨糖蛋白-39 对氧磷酶-1 迟发性脑水肿

2024

保健医学研究与实践
西南大学

保健医学研究与实践

CSTPCD
影响因子:0.512
ISSN:1673-873X
年,卷(期):2024.21(10)